Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Ji-ye Zhu"'
Autor:
Shi-hua Hu, Long-hui Zhang, Jie Gao, Jing-heng Guo, Xiao-dong Xun, Xiao Xiang, Qian Cheng, Zhao Li, Ji-ye Zhu
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Numerous studies reported a small subpopulation of TCRαβ+CD4-CD8- (double-negative) T cells that exert regulatory functions in the peripheral lymphocyte population. However, the origin of these double-negative T (DNT) cells is controversial. Some r
Externí odkaz:
https://doaj.org/article/920e17d260274637a68be0624da7dc81
Autor:
Zhong-Tian Jin, Kun Li, Mei Li, Zhi-Gang Ren, Fu-Shun Wang, Ji-Ye Zhu, Xi-Sheng Leng, Wei-Dong Yu
Publikováno v:
Chinese Medical Journal, Vol 128, Iss 4, Pp 545-549 (2015)
Background: Overexpression of G-protein coupled receptor 34 (GPR34) affects the progression and prognosis of human gastric adenocarcinoma, however, the role of GPR34 in gastric cancer development and progression has not been well-determined. The curr
Externí odkaz:
https://doaj.org/article/fb7d38f8b6534ed4af8b63ee67909b6b
Autor:
Hui Liu, Wai Ho Oscar Yeung, Li Pang, Jiang Liu, Xiao Bing Liu, Kevin Tak Pan Ng, Qingmei Zhang, Wen Qi Qiu, Yueqin Zhu, Tao Ding, Zhe Wang, Ji Ye Zhu, Chung Mau Lo, Kwan Man
Publikováno v:
JHEP Reports, Vol 5, Iss 12, Pp 100895- (2023)
Background & Aims: The steatotic grafts have been applied in liver transplantation frequently owing to the high incidence of non-alcoholic fatty liver disease. However, fatty livers are vulnerable to graft injury. Myeloid-derived suppressor cell (MDS
Externí odkaz:
https://doaj.org/article/e21c8487ebcc436c818307656adade91
Autor:
Kwan Man, Wen Qi Qiu, Jiang Liu, Li Pang, Ji Ye Zhu, Matthew Yh Lau, YF Lam, Hui Liu, Chung Mau Lo, Man Kit Lai, Kevin Tak-Pan Ng, Oscar Wai Ho Yeung, Xin Xiang Yang, Hoi Chung Shiu, Weiyi Zhang
Publikováno v:
Cell Death Discovery
Cell Death Discovery, Vol 7, Iss 1, Pp 1-14 (2021)
Cell Death Discovery, Vol 7, Iss 1, Pp 1-14 (2021)
Hepatocellular carcinoma (HCC) recurrence after liver transplantation remains a significant clinical problem. Ischemia-reperfusion injury (IRI) occurred inevitably at the early phase after liver transplantation (LT) spawns a significant risk of HCC r
Publikováno v:
Journal of Hepatology. 73:S134-S136
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2019 (2019)
BioMed Research International, Vol 2019 (2019)
Cancer metastasis has been demonstrated as it is the culmination of a cascade of priming steps. Increasing evidence has shown that tumor-derived molecular components (TDMCs) are known as extra cellular vesicle and nonvesicle factors and serve as vers
Publikováno v:
OncoTargets and therapy
Qian Cheng,1 Tan-jun Tong,2 Zhao Li,1 Shi-hua Hu,1 Ding-bao Chen,1 Si-qi Wang,1 Ji-ye Zhu1 1Peking University Institute of Organ Transplantation, Peking University Center of Liver Cancer Diagnosis and Treatment, Beijing Key Surgical Basic Research La
Publikováno v:
Journal of Clinical Pathology. 72:295-303
AimsTo evaluate stromal histopathological features and immunostaining expression for differential diagnosis of low- and high-grade dysplastic nodules (HGDN) to early and progressed hepatocellular carcinomas (eHCC, pHCC).MaterialsWe evaluated sinusoid
Autor:
Kevin Tak-Pan NG, Oscar Wai-Ho Yeung, Yin Fan Lam, Jiang Liu, Hui Liu, Li Pang, Xin Xiang Yang, Ji Ye Zhu, Wei yi Zhang, Matthew YH Lau, Wen Qi Qiu, Hoi Chung Shiu, Man Kit Lai, Chung Mau Lo, Kwan Man
BackgroundAn inevitable hepatic injury at the early phase after liver transplantation vitally affects the late phase hepatocellular carcinoma (HCC) recurrence. However, their linkage and underlying risk factors of HCC recurrence are unclear. This stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c54d371a18ff67cdbdbbdd8a4b290561
https://doi.org/10.21203/rs.3.rs-97857/v1
https://doi.org/10.21203/rs.3.rs-97857/v1
Autor:
Wei Hua, Zhu, Wen Yong, Xie, Zhe Dong, Zhang, Shu, Li, Da Fang, Zhang, Yi Jun, Liu, Ji Ye, Zhu, Xi Sheng, Leng
Publikováno v:
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih. 35(2)
Objective Hilar cholangiocarcinoma (HC) is invariably fatal without surgical resection. The primary aim of the current study was to determine the safety of variable surgical resections for patient with HC and their survival after surgical resection.